Contagion® will be providing exclusive coverage on the conference, and so, keep your eyes peeled for session coverage and interviews with some of the key presenters.
Contagion® will be heading to Boston, Massachusetts at the end of the week to report on the annual Conference on Retroviruses and Opportunistic Infections (CROI), a forum that brings together researchers from around the world to discuss the latest research to help in the battle against HIV/AIDS and other related infectious diseases.
As a trusted source in the realm of HIV, the editorial team of Contagion® strives to consistently report on new developments made in the fight against the virus. Some of our recent coverage includes the recent warning released by the US Food and Drug Administration regarding the potential long-term risks of clarithromycin in patients with heart disease, something more and more HIV patients are facing; research that suggests that pre-exposure prophylaxis does not have to be taken on a daily basis to be effective; and how cannabis use may work to reduce HIV-associated inflammation and immune activation in individuals on antiretroviral therapy.
What’s on the docket for the conference this year? Coverage will be focused on patient outcomes after switching therapies, for example, from dolutegravir to the recently approved bictegravir or to darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF). Actions being taken to combat drug resistance will also be covered, as will improvements for the prevention and treatment of tuberculosis. Additional coverage will focus on increasing access to PrEP in women and underserved populations such as transgender individuals and others who are met with barriers across the HIV care continuum.
In keeping with our dedication to providing our readership with the most timely and relevant content to support their practices and improve patient outcomes, Contagion® editors will provide exclusive written coverage, along with engaging video interviews several key opinion leaders on important issues and advancements made in the realm of infectious disease.
Some of the presentations that we will cover in the upcoming week include one from Harold W. Jaffe, from the Centers for Disease Control and Prevention, who will reflect on the early days of AIDS, and from JoAnne L. Flynn, PhD, from the University of Pittsburg, who will provide insight into tuberculosis prevention; Nichole Klatt, PhD, from the University of Washington, who will discuss the vaginal microbiome and the acquisition of HIV and Robert H. Remien, PhD, from New York State Psychiatric Institute and Columbia University, who will stress that addressing mental health is a critical component to ending the HIV epidemic; as well as Patricia M. Flynn, MD, from St. Jude’s Childrens Research Hospital, who will provide insight into growing up with HIV and Helen A. Weiss, PhD, from the London School of Hygiene & Tropical Medicine, will answer the question of if we are on a fast track to “bend and end” HIV epidemics.
Going to the conference? Be sure to say hello between interviews or sessions; we'll be there!
Not going to the conference? Be sure to sign up for our Conference updates.